We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




GITR Stimulation Can Break Immunologic Self-Tolerance

By Biotechdaily staff writers
Posted on 01 Apr 2004
A recent study has elucidated the cellular mechanism that allows the persistence of chronic viral infections such as herpes, hepatitis, and AIDS and suggests a treatment.

Investigators at the [U.S.] National Institute of Allergy and Infectious Diseases' Rocky Mountain Laboratories (Hamilton, MT, USA) infected mice with Friend virus (FV) and studied the response of various immune cell fractions by transferring them from healthy mice into the infected animals. More...
They wrote in the March 2004 issue of Immunity that virus-specific CD8+ T-cells proliferated and appeared activated, but failed to produce gamma interferon or reduce virus loads. Production of gamma interferon was suppressed by a subpopulation of CD4+ T cells.

Treatment of persistently infected mice with anti-GITR antibody significantly improved gamma interferon production by transferred CD8+ T-cells and allowed a significant reduction in viral loads. GITR (glucocorticoid-induced TNFR family related gene) is a member of the TNF receptor superfamily (TNFRSF18). Its ligand is GITRL (AITRL), which is expressed on both immature and mature dendritic cells, and endothelial cells. A high level of GITR is constitutively expressed on CD4+ regulatory T-cells. GITR plays an important role in the regulation of T-cell proliferation and TCR-mediated apoptosis. Furthermore, stimulation of GITR can break immunologic self-tolerance.

Senior author Dr. Kim J. Hasenkrug, an investigator at Rocky Mountain Laboratories explained, "A practical intervention that could reduce virus loads during chronic HIV infection would likely be an invaluable tool in postponing the onset of AIDS. While it remains to be seen whether an intervention such as described in our study would work in HIV infections, our experiments open new possibilities of therapy for treating persistence, one of the most refractory elements of retroviral infections.”



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.